Acyl amino acid derivatives as novel inhibitors of influenza neuraminidase

14Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We searched our chemical collection to identify non-N-acetylneuraminate (NeuAC) inhibitors of influenza neuraminidase (NA). Of the 62 acyl derivatives tested, several acyl amino acids, but not acyl alkanolamine derivatives, were effective and inhibited the NA activity in a dose-dependent manner. N-3-Hydroxymyristoyl d-cysteine and N-myristoyl-O-caproyl-d-serine were the more potent compounds and inhibited the enzyme in a noncompetitive manner (Ki = 102 and 125 μ m, respectively) without respect to the substrate. An important consideration for the choice of inhibitor is the selectivity of the inhibition. These compounds were selective inhibitors of viral NA and effective for any variant enzyme, but the enzymes from V. cholerae and human placenta were insensitive. Accordingly, the acyl amino acid derivatives may be expected to be inhibitors without cellular toxicity and may serve as lead compounds for anti-influenza agents. © 1997, Taylor & Francis Group, LLC. All rights reserved.

Cite

CITATION STYLE

APA

Kondoh, M., Furutani, T., Azuma, M., Ooshima, H., & Kato, J. (1997). Acyl amino acid derivatives as novel inhibitors of influenza neuraminidase. Bioscience, Biotechnology and Biochemistry, 61(5), 870–874. https://doi.org/10.1271/bbb.61.870

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free